April for the 2nd Interim and late June for the Final Data announcement..
What's important to keep in mind is that with Positive Phase II Results SNT 5505 becomes a target for Big Pharma ,,, they don't really require SNT "the Company" for the Phase III..
The most probable outcome will be an early Equity position to establish a relationship and ward off any other speculative Pharma's with Milestones of success for a Take out of SNT 5505...
I'm amazed we haven't seen more announcements surrounding the UK Parkinson Trial ,, now that dosing has been completed NZT
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.004(7.02%) |
Mkt cap ! $86.12M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 4.9¢ | $5.887M | 127.7M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 107994 | 3 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| SNT (ASX) Chart |